Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs AquaVita NextGen

Alan Meds
Graded #99

Higher grade

vs+14.799999999999997
AquaVita NextGen
Graded #416

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 56.3/100.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +49
72
23
Dose & formulationEven
75
75
Clinical oversightEven
82
82
Labs & monitoringEven
53
53
FulfillmentAlan Meds +16
78
62
Contract termsAlan Meds +8
55
47
Alan Meds · left barAquaVita NextGen · right bar

The numbers

MetricAlan MedsAquaVita NextGen
WeighScore71.1/10056.3/100
GradeCC
Scorecard rank#99#416
Semaglutide$158/mo (compounded)$375/mo (first-month rate, compounded)
Tirzepatide$295/mo (compounded)$320/mo (starting dose, 3-month plan, compounded)
Coverage46 states5 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Alan Meds

Graded #99 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
AquaVita NextGen

Graded #416 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

Where it loses points

  • Only 5 states (AZ, CA, FL, TX, NV)
  • No LegitScript or PCAB accreditation
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard